Detalhe da pesquisa
1.
Sequencing of New and Old Therapies for Metastatic Melanoma.
Curr Treat Options Oncol
; 17(10): 52, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27515170
2.
Real-world outcomes with immuno-oncology therapies in advanced melanoma: final results of the OPTIMIzE registry study.
Immunotherapy
; 16(1): 29-42, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37937397
3.
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline.
J Clin Oncol
; 42(13): 1575-1593, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478773
4.
Characteristics of patients with hematologic malignancies without seroconversion post-COVID-19 third vaccine dosing.
Biol Methods Protoc
; 8(1): bpad002, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36873569
5.
A Prospective, Longitudinal Evaluation of SARS-CoV-2 COVID-19 Exposure, Use of Protective Equipment and Social Distancing in a Group of Community Physicians.
Healthcare (Basel)
; 10(2)2022 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35206899
6.
Real-World Third COVID-19 Vaccine Dosing and Antibody Response in Patients With Hematologic Malignancies.
J Patient Cent Res Rev
; 9(3): 149-157, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35935520
7.
Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564126
8.
Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update.
J Clin Oncol
; 40(7): 787-800, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35041467
9.
An Open-Label, Randomized, Multi-Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin-2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma.
Oncoimmunology
; 10(1): 1984059, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34650833
10.
Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma.
J Clin Oncol
; 39(34): 3829-3838, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34464163
11.
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.
J Clin Oncol
; 39(24): 2647-2655, 2021 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33945288
12.
Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline.
J Clin Oncol
; 36(5): 492-511, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29227723
13.
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.
J Clin Oncol
; 36(17): 1714-1768, 2018 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29442540
14.
Management of Breast Cancer during Pregnancy: Are We Compliant with Current Guidelines?
AJP Rep
; 7(1): e39-e43, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28255521
15.
Vemurafenib treatment for patients with locally advanced, unresectable stage IIIC or metastatic melanoma and activating exon 15 BRAF mutations other than V600E.
Melanoma Res
; 27(6): 585-590, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29076950
16.
Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM.
Clin Genitourin Cancer
; 15(1): 31-41.e4, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27916626
17.
Real-world treatment practice in patients with advanced melanoma in the era before ipilimumab: results from the IMAGE study.
Cancer Med
; 5(7): 1436-43, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27118102
18.
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.
Head Neck
; 38(12): 1752-1758, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27407058
19.
A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.
J Immunother Cancer
; 4: 52, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27660706
20.
High-Dose Radiation as a Dramatic, Immunological Primer in Locally Advanced Melanoma.
Cureus
; 7(12): e417, 2015 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-26848410